BX Swiss TOP 30 CHF
|
1 288,30
|
-13,91
|
-1,07 %
|
Analysen zu BX Swiss TOP 30 CHF-Werten
| 20.03.26 | Novartis Equal Weight | Barclays Capital | |
| 20.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 19.03.26 | ABB Sector Perform | RBC Capital Markets | |
| 19.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Nestlé Sector Perform | RBC Capital Markets | |
| 18.03.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.03.26 | UBS Underweight | Barclays Capital | |
| 17.03.26 | Givaudan Overweight | Barclays Capital | |
| 17.03.26 | Givaudan Neutral | UBS AG | |
| 12.03.26 | Roche Hold | Deutsche Bank AG | |
| 12.03.26 | Roche Overweight | Barclays Capital | |
| 12.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.03.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | Roche Hold | Deutsche Bank AG | |
| 10.03.26 | UBS Underweight | Barclays Capital | |
| 10.03.26 | Givaudan Overweight | Barclays Capital | |
| 09.03.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 09.03.26 | Roche Overweight | Barclays Capital | |
| 09.03.26 | Roche Hold | Deutsche Bank AG | |
| 09.03.26 | Roche Outperform | Bernstein Research | |
| 09.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.03.26 | Roche Underperform | Jefferies & Company Inc. | |
| 09.03.26 | UBS Outperform | RBC Capital Markets | |
| 06.03.26 | Richemont Buy | UBS AG | |
| 06.03.26 | Roche Buy | UBS AG | |
| 06.03.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 06.03.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 03.03.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 03.03.26 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 03.03.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 02.03.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 02.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 02.03.26 | Swiss Re Underperform | RBC Capital Markets | |
| 27.02.26 | Swiss Re Neutral | UBS AG | |
| 27.02.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 27.02.26 | Swiss Re Underperform | RBC Capital Markets |